Literature DB >> 15068631

Artifactually elevated serum-free thyroxine levels measured by equilibrium dialysis in a pregnant woman with familial dysalbuminemic hyperthyroxinemia.

Saeko Hoshikawa1, Kouki Mori, Nobuko Kaise, Yoshinori Nakagawa, Sadayoshi Ito, Katsumi Yoshida.   

Abstract

Familial dysalbuminemic hyperthyroxinemia (FDH) is a familial autosomal dominant syndrome caused by abnormal albumin with an increased affinity for thyroxine (T4). Two types of mutations in the albumin gene, replacing the normal arginine 218 with a histidine (R218H) or a proline (R218P), have been reported to cause FDH. Here, we report a pregnant Japanese woman with FDH caused by the mutant albumin R218P. She had extremely elevated total T4 levels but normal TSH. While the majority of T4was bound to albumin, T4 binding to thyroxine-binding globulin (TBG) was progressively increased throughout pregnancy. Her infant also had elevated serum T4 but normal thyrotropin (TSH). The presence of a guanine to cytosine transition in the second nucleotide of codon 218 of the albumin gene, resulting in a substitution of proline for the normal arginine (R218P), was revealed in the proband. Serum free thyroxine (FT4) levels were increased when measured with some commercial kits including equilibrium dialysis followed by radioimmunoassay (RIA) but not when determined by RIA after ultrafiltration of sera. These results indicate an increased T4 binding to TBG during pregnancy in the patients with FDH. Furthermore, our results suggest that normal serum FT4 determined by equilibrium dialysis is not an ultimate standard for the diagnosis of FDH in the patients with the mutant albumin R218P.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15068631     DOI: 10.1089/105072504322880409

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  6 in total

1.  Familial dysalbuminemic hyperthyroxinemia in a 4-year-old girl with hyperactivity, palpitations and advanced dental age: how gold standard assays may be misleading.

Authors:  Abha Choudhary; Chutintorn Sriphrapradang; Samuel Refetoff; Zoltan Antal
Journal:  J Pediatr Endocrinol Metab       Date:  2015-01       Impact factor: 1.634

2.  Familial Dysalbuminemic Hyperthyroxinemia in a Japanese Man Caused by a Point Albumin Gene Mutation (R218P).

Authors:  Yoshinori Osaki; Yoshitaka Hayashi; Yoshinori Nakagawa; Katsumi Yoshida; Hiroshi Ozaki; Hiroshi Fukazawa
Journal:  Jpn Clin Med       Date:  2016-04-04

3.  Familial Dysalbuminemic Hyperthyroxinemia that was Inappropriately Treated with Thiamazole Due to Pseudo-thyrotoxic Symptoms.

Authors:  Takahiro Fukaishi; Yoshihiro Sekiguchi; Yoshihito Hara
Journal:  Intern Med       Date:  2017-08-01       Impact factor: 1.271

4.  Effect of Albumin Polymorphism on Thyroid Hormones: A Case Report and Literature Review.

Authors:  Rupak Mahendhar; Amir Shahbaz; Maria Riaz; Michael Aninyei; David M Reich; Issac Sachmechi
Journal:  Cureus       Date:  2018-07-01

Review 5.  Human serum albumin variants in China: a molecular epidemiological investigation and literature review.

Authors:  Jiao-Ren Wu; Min Lin; Fen Lin; Xiao-Fen Zhan; Jun-Li Wang; Hui Yang; Zhao-Yun Luo; Zhan-Zhong Ma; Chun-Fang Wang; Li-Ye Yang
Journal:  J Int Med Res       Date:  2021-12       Impact factor: 1.671

Review 6.  Clinical, Genetic, and Protein Structural Aspects of Familial Dysalbuminemic Hyperthyroxinemia and Hypertriiodothyroninemia.

Authors:  Ulrich Kragh-Hansen; Monica Galliano; Lorenzo Minchiotti
Journal:  Front Endocrinol (Lausanne)       Date:  2017-11-01       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.